Related Experiment Video
Updated: Jul 5, 2025

Bioluminescent Bacterial Imaging In Vivo
Published on: November 4, 2012
Bacteria-based drug delivery for treating non-oncological diseases
Zhenping Cao1, Yan Pang2, Jun Pu3
1Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, Institute of Molecular Medicine, State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
Living bacteria are engineered as therapeutic agents for drug delivery, effectively treating non-oncological diseases in various body sites like the skin and gut. This review explores their potential and challenges for future medical applications.
Area of Science:
- Microbiology
- Biotechnology
- Drug Delivery Systems
Background:
- Bacteria naturally colonize diverse human body sites, including skin, gut, and respiratory tract.
- Bacterial properties like rapid proliferation, colonization, and biomolecule production enable their use as therapeutic agents.
- Genetic engineering and surface modification offer flexibility in developing bacteria-based drug delivery systems.
Purpose of the Study:
- To provide an overview of bacteria-based drug delivery systems.
- To explore applications in treating non-oncological diseases.
- To summarize key considerations for clinical translation.
Main Methods:
- Systematic review of literature on bacteria-based drug delivery.
- Analysis of bacterial colonization sites (skin, GI, respiratory, urogenital tracts).
- Discussion of therapeutic applications in specific diseases (wound healing, IBD, respiratory diseases, vaginitis).
Main Results:
- Bacteria-based drug delivery shows promise for treating localized non-oncological diseases.
- Successful applications demonstrated in skin infections, inflammatory bowel disease, respiratory conditions, and vaginitis.
- Identified advantages and limitations of using living bacterial therapeutics.
Conclusions:
- Bacteria-based drug delivery systems offer a novel therapeutic approach for various non-oncological conditions.
- Further research is needed to address limitations and facilitate clinical translation.
- This review provides insights for developing next-generation bacteria-based therapeutics.
Related Concept Videos
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Drug Delivery: Enteral Route
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Routes of Drug Administration: Enteral
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
Bacterial Signaling

